pharma · Solid Tumor, Adult · Advanced Soft-tissue Sarcoma · MNPR
Monopar Therapeutics
Monopar Therapeutics clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Wilmette, USA
- Founded
- 2015
- Employees
- 22
- Programs
- 4
- Drugs
- 3
- Patents
- 3
Monopar Therapeutics projects
4 ClinicalTrials.gov programs sponsored by Monopar Therapeutics.
Monopar Therapeutics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Clonidine HCl Mucoadhesive Buccal Tablet
Monopar Therapeutics
Chemoradiotherapy-Induced Severe Oral Mucositis
1 trial -
Camsirubicin
Monopar Therapeutics
Advanced Soft-tissue Sarcoma
1 trial -
MNPR-101-DFO*-89Zr
Monopar Therapeutics
Solid Tumor, Adult
1 trial -
MNPR-101-PCTA-177Lu
Monopar Therapeutics
Solid Tumor, Adult
1 trial
Frequently asked questions
How many clinical projects does Monopar Therapeutics have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.